In an abrupt and surprising twist, the CEO of Ozempic-maker Novo Nordisk has been ousted from his position as the head of the ...

Novo Nordisk's CEO, Lars Fruergaard Jorgensen, will step down amidst market challenges and a significant stock price drop, ...

Novo Nordisk’s new top executive will need to help the company close the gap with Eli Lilly, fend off emerging rivals and ...

known for its blockbuster diabetes and weight-loss treatments Ozempic and Wegovy, said Friday its chief executive was stepping down in the wake of "market challenges". The company said the ...

Pharmaceutical company Novo Nordisk, maker of blockbuster weight loss drug Wegovy, says its CEO is stepping down ...

Related Ozempic shows promise in treating fatty ... off' Americans Company share prices have declined amid the market challenges and an accelerated CEO succession was decided after "a dialogue ...

Ozempic and Wegovy maker Novo Nordisk ousted ... “The changes are made in light of the recent market challenges Novo Nordisk has been facing, and the development of the company’s share price ...